Compounding Pharmacies Market is expected to reach US$ 12.65 Bn. at a CAGR of 4% during the forecast period 2029. Favourable demographic inclinations towards improved life expectancy coupled with rising geriatric population will render substantial positive impact on Global Compounding Pharmacies Market growth. Patient of old age normally needs dosage forms and drug excipients that are unalike from commercially available products in market. In such circumstances, compounded medications tailor-made to individual needs allow superior handling of disease conditions. As a result, growing number of geriatric population will boost the market for compounded medications.To know about the Research Methodology:-Request Free Sample Report Dearth of availability of skilled workforce coupled with high cost of sophisticated equipment required for compounding medicines might hamper the market growth by 2024. Continuously, changing regulations will further hinder the industry growth affecting the production of compounded drugs on large scale. Lack of timely availability of customary drugs will lead the demand for compounded medications. Shortage of drugs might have severe repercussion such as death of patients. For instance, Europe and North America region have witnessed substantial drug shortage over past few years. Oral product segment from Global Market accounted for highest market share in 2022. The high market value is owed to the growing demand for compounded oral medicine, particularly in the domain of pain management. Additionally, the oral liquid dosage forms are favoured due to associated ease of administration and convenience. Geriatric people time and again desire liquid oral dosage form in auxiliary to commercially available dosage forms. Adult application segment will show a robust growth over the upcoming years. Increasing prevalence of cardiovascular, respiratory oncology, viral, and bacterial diseases in adult population will mainly boost the segment growth. Women over the age of 40years suffering from hormonal changes in their body require compounded hormonal medications. This will additionally support the segment growth over the forecast timeframe.
Compounding Pharmacies Market Scope: Inquire before buying
Global Compounding Pharmacies Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 9.61 Bn. Forecast Period 2023 to 2029 CAGR: 4 % Market Size in 2029: US $ 12.65 Bn. Segments Covered: by Product Oral Solid preparations Tablets Capsules Granules Powder Others Liquid preparations Solutions Suspension Emulsion Syrup Others Topical Ointments Creams Gels Pastes Others Rectal Suppositories Edema Others Parenteral Inhaler Ophthalmic Eye drops Ear drops Nasal drops Others by Application Pediatrics Adult Geriatric Veterinary Therapeutic Area Hormone Replacement Pain Management by Therapeutic Area Dermatology Pain management Specialty drugs Nutritional supplements Hormone replacement Others Compounding Pharmacies Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Key Players
1. B. BraunAthenex Pharma Solutions 2. Fresenius Kabi 3. Clinigen Group PLC 4. Dougherty's Pharmacy, Inc. 5. Fagron 6. Lorraine’s Pharmacy 7. Institutional Pharmacy Solutions 8. McGuff Company Inc. 9. Nephron Pharmaceuticals Corporation 10. Rx3 Compounding Pharmacy 11. Wedgewood Village Pharmacy, Inc. 12. Pencol Compounding Pharmacy 13. Triangle Compounding Pharmacies 14. Wedgewood Village Pharmacy, Inc. 15. PharMEDium Services, LLC 16. Cantrell Drug Company 17. Elixir Compounding Pharmacy 18. Avella specialty pharmacy 19. US Compounding Inc 20. Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd Frequently Asked Questions: 1] What segments are covered in the Compounding Pharmacies Market report? Ans. The segments covered in the Market report are based on Product and application. 2] Which region is expected to hold the highest share in the Compounding Pharmacies Market? Ans. The Asia Pacific region is expected to hold the highest share in the Compounding Pharmacies Market. 3] What is the market size of the Compounding Pharmacies Market by 2029? Ans. The market size of the Compounding Pharmacies Market by 2029 is US$ 12.65 Bn. 4] What is the forecast period for the Compounding Pharmacies Market? Ans. The forecast period for the Compounding Pharmacies Market is 2023-2029. 5] What was the market size of the Compounding Pharmacies Market in 2022? Ans. The market size of the Compounding Pharmacies Market in 2022 was US$ 9.61 Bn.
1. Global Compounding Pharmacies Market: Research Methodology 2. Global Compounding Pharmacies Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Compounding Pharmacies Market 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Compounding Pharmacies Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • South America 3.12 COVID-19 Impact 4. Global Compounding Pharmacies Market Segmentation 4.1 Global Compounding Pharmacies Market, by Product (2022-2029) • Oral o Solid preparations Tablets Capsules Granules Powder Others o Liquid preparations Solutions Suspension Emulsion Syrup Others • Topical o Ointments o Creams o Gels o Pastes o Others • Rectal o Suppositories o Edema o Others • Parenteral • Inhaler • Ophthalmic o Eye drops o Ear drops o Nasal drops o Others 4.2 Global Compounding Pharmacies Market, by Application (2022-2029) • Pediatrics • Adult • Geriatric • Veterinary Therapeutic Area • Hormone Replacement • Pain Management 4.3 Global Compounding Pharmacies Market, by Therapeutic Area (2022-2029) • Dermatology • Pain management • Specialty drugs • Nutritional supplements • Hormone replacement • Others 5. North America Compounding Pharmacies Market(2022-2029) 5.1 North America Compounding Pharmacies Market, by Product (2022-2029) • Oral o Solid preparations Tablets Capsules Granules Powder Others o Liquid preparations Solutions Suspension Emulsion Syrup Others • Topical o Ointments o Creams o Gels o Pastes o Others • Rectal o Suppositories o Edema o Others • Parenteral • Inhaler • Ophthalmic o Eye drops o Ear drops o Nasal drops o Others 5.2 North America Compounding Pharmacies Market, by Application (2022-2029) • Pediatrics • Adult • Geriatric • Veterinary Therapeutic Area • Hormone Replacement • Pain Management 5.3 North America Compounding Pharmacies Market, by Therapeutic Area (2022-2029) • Dermatology • Pain management • Specialty drugs • Nutritional supplements • Hormone replacement • Others 5.4 North America Compounding Pharmacies Market, by Country (2022-2029) • United States • Canada • Mexico 6. Europe Compounding Pharmacies Market (2022-2029) 6.1. European Compounding Pharmacies Market, by Product (2022-2029) 6.2. European Compounding Pharmacies Market, by Application (2022-2029) 6.3. European Compounding Pharmacies Market, by Therapeutic Area (2022-2029) 6.4. European Compounding Pharmacies Market, by Country (2022-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Compounding Pharmacies Market (2022-2029) 7.1. Asia Pacific Compounding Pharmacies Market, by Product (2022-2029) 7.2. Asia Pacific Compounding Pharmacies Market, by Application (2022-2029) 7.3. Asia Pacific Compounding Pharmacies Market, by Therapeutic Area (2022-2029) 7.4. Asia Pacific Compounding Pharmacies Market, by Country (2022-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa Compounding Pharmacies Market (2022-2029) 8.1 Middle East and Africa Compounding Pharmacies Market, by Product (2022-2029) 8.2. Middle East and Africa Compounding Pharmacies Market, by Application (2022-2029) 8.3. Middle East and Africa Compounding Pharmacies Market, by Therapeutic Area (2022-2029) 8.4. Middle East and Africa Compounding Pharmacies Market, by Country (2022-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Compounding Pharmacies Market (2022-2029) 9.1. South America Compounding Pharmacies Market, by Product (2022-2029) 9.2. South America Compounding Pharmacies Market, by Application (2022-2029) 9.3. South America Compounding Pharmacies Market, by Therapeutic Area (2022-2029) 9.4 South America Compounding Pharmacies Market, by Country (2022-2029) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1 B. BraunAthenex Pharma Solutions 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2 Fresenius Kabi 10.3 Clinigen Group PLC 10.4 Dougherty's Pharmacy, Inc. 10.5 Fagron 10.6 Lorraine’s Pharmacy 10.7 Institutional Pharmacy Solutions 10.8 McGuff Company Inc. 10.9 Nephron Pharmaceuticals Corporation 10.10 Rx3 Compounding Pharmacy 10.11 Wedgewood Village Pharmacy, Inc. 10.12 Pencol Compounding Pharmacy 10.13 Triangle Compounding Pharmacies 10.14 Wedgewood Village Pharmacy, Inc. 10.15 PharMEDium Services, LLC 10.16 Cantrell Drug Company 10.17 Elixir Compounding Pharmacy 10.18 Avella specialty pharmacy 10.19 US Compounding Inc